WallStreetZenWallStreetZen

NASDAQ: GMDA
Gamida Cell Ltd Stock Forecast, Predictions & Price Target

Buy GMDA

Analyst price target for GMDA

Based on 2 analysts offering 12 month price targets for Gamida Cell Ltd.
Min Forecast
$12.00+387.8%
Avg Forecast
$13.50+448.78%
Max Forecast
$15.00+509.76%

Should I buy or sell GMDA stock?

Based on 2 analysts offering ratings for Gamida Cell Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

GMDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Needham
Top 8%
93
BuyMaintains$12.00+387.80%2021-11-16
Oppenheimer
Top 34%
67
BuyMaintains$15.00+509.76%2021-11-16

1 of 1

Forecast return on equity

Is GMDA forecast to generate an efficient return?
Company
76.78%
Industry
38.08%
Market
28.93%
GMDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GMDA forecast to generate an efficient return on assets?
Company
15.4%
Industry
13.32%
GMDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GMDA earnings per share forecast

What is GMDA's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.22
Avg 2 year Forecast
-$1.05
Avg 3 year Forecast
-$0.14

GMDA revenue forecast

What is GMDA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$50.5M
Avg 2 year Forecast
$20.1M
Avg 3 year Forecast
$72.5M

GMDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GMDA$2.46$13.50+448.78%Buy
ADVM$1.49$4.00+168.46%Strong Buy
EVLO$2.71$26.75+887.08%Strong Buy
SLGL$6.27$18.50+194.96%Strong Buy
WVE$2.45$5.50+124.49%Buy

Gamida Cell Stock Forecast FAQ

Is Gamida Cell Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GMDA) stock is to Buy GMDA stock.

Out of 2 analysts, 0 (0%) are recommending GMDA as a Strong Buy, 2 (100%) are recommending GMDA as a Buy, 0 (0%) are recommending GMDA as a Hold, 0 (0%) are recommending GMDA as a Sell, and 0 (0%) are recommending GMDA as a Strong Sell.

If you're new to stock investing, here's how to buy Gamida Cell stock.

What is GMDA's earnings growth forecast for 2022-2024?

(NASDAQ: GMDA) Gamida Cell's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.41%.

Gamida Cell's earnings in 2022 is -$91,977,000.On average, 3 Wall Street analysts forecast GMDA's earnings for 2022 to be -$73,134,484, with the lowest GMDA earnings forecast at -$76,731,261, and the highest GMDA earnings forecast at -$65,341,465. On average, 3 Wall Street analysts forecast GMDA's earnings for 2023 to be -$62,943,613, with the lowest GMDA earnings forecast at -$80,927,502, and the highest GMDA earnings forecast at -$45,559,186.

In 2024, GMDA is forecast to generate -$8,392,482 in earnings, with the lowest earnings forecast at -$8,392,482 and the highest earnings forecast at -$8,392,482.

What is GMDA's revenue growth forecast for 2022-2024?

(NASDAQ: GMDA) Gamida Cell's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.55%.

Gamida Cell's revenue in 2022 is $0.On average, 3 Wall Street analysts forecast GMDA's revenue for 2022 to be $3,028,666,814, with the lowest GMDA revenue forecast at $256,570,155, and the highest GMDA revenue forecast at $8,086,755,600. On average, 3 Wall Street analysts forecast GMDA's revenue for 2023 to be $1,207,498,281, with the lowest GMDA revenue forecast at $779,301,874, and the highest GMDA revenue forecast at $1,882,313,757.

In 2024, GMDA is forecast to generate $4,346,706,068 in revenue, with the lowest revenue forecast at $4,346,706,068 and the highest revenue forecast at $4,346,706,068.

What is GMDA's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: GMDA) forecast ROA is 15.4%, which is higher than the forecast US Biotechnology industry average of 13.32%.

What is GMDA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GMDA price target, the average GMDA price target is $13.50, with the highest GMDA stock price forecast at $15.00 and the lowest GMDA stock price forecast at $12.00.

On average, Wall Street analysts predict that Gamida Cell's share price could reach $13.50 by Nov 16, 2022. The average Gamida Cell stock price prediction forecasts a potential upside of 448.78% from the current GMDA share price of $2.46.

What is GMDA's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: GMDA) Gamida Cell's current Earnings Per Share (EPS) is -$1.55. On average, analysts forecast that GMDA's EPS will be -$1.22 for 2022, with the lowest EPS forecast at -$1.28, and the highest EPS forecast at -$1.09. On average, analysts forecast that GMDA's EPS will be -$1.05 for 2023, with the lowest EPS forecast at -$1.35, and the highest EPS forecast at -$0.76. In 2024, GMDA's EPS is forecast to hit -$0.14 (min: -$0.14, max: -$0.14).

What is GMDA's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: GMDA) forecast ROE is 76.78%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.